Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
by
Gary, Thomas
, Samonigg, Hellmut
, Gerger, Armin
, Bauernhofer, Thomas
, Fankhauser, Christian D.
, Hermanns, Thomas
, Beyer, Joerg
, Hutterer, Georg C.
, Posch, Florian
, Ploner, Ferdinand
, Pichler, Martin
, Bezan, Angelika
, Szkandera, Joanna
, Winder, Thomas
, Stotz, Michael
, Pummer, Karl
in
Adult
/ Biology and Life Sciences
/ Chemotherapy
/ Classifiers
/ Empirical analysis
/ Epidemiology
/ Health risk assessment
/ Health risks
/ Hospitals
/ Humans
/ Incidence
/ Internal medicine
/ Lymphadenopathy
/ Male
/ Mathematical models
/ Medical imaging
/ Medical research
/ Medicine
/ Medicine and Health Sciences
/ Metastases
/ Metastasis
/ Mortality
/ Neoplasms, Germ Cell and Embryonal - complications
/ Neoplasms, Germ Cell and Embryonal - pathology
/ Oncology
/ Patients
/ Prediction models
/ Retrospective Studies
/ Risk analysis
/ Risk Factors
/ Testes
/ Testicular cancer
/ Testicular Neoplasms - complications
/ Testicular Neoplasms - pathology
/ Thromboembolism
/ Thrombosis
/ Tomography
/ Tumors
/ Urology
/ Venous Thromboembolism - etiology
2017
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
by
Gary, Thomas
, Samonigg, Hellmut
, Gerger, Armin
, Bauernhofer, Thomas
, Fankhauser, Christian D.
, Hermanns, Thomas
, Beyer, Joerg
, Hutterer, Georg C.
, Posch, Florian
, Ploner, Ferdinand
, Pichler, Martin
, Bezan, Angelika
, Szkandera, Joanna
, Winder, Thomas
, Stotz, Michael
, Pummer, Karl
in
Adult
/ Biology and Life Sciences
/ Chemotherapy
/ Classifiers
/ Empirical analysis
/ Epidemiology
/ Health risk assessment
/ Health risks
/ Hospitals
/ Humans
/ Incidence
/ Internal medicine
/ Lymphadenopathy
/ Male
/ Mathematical models
/ Medical imaging
/ Medical research
/ Medicine
/ Medicine and Health Sciences
/ Metastases
/ Metastasis
/ Mortality
/ Neoplasms, Germ Cell and Embryonal - complications
/ Neoplasms, Germ Cell and Embryonal - pathology
/ Oncology
/ Patients
/ Prediction models
/ Retrospective Studies
/ Risk analysis
/ Risk Factors
/ Testes
/ Testicular cancer
/ Testicular Neoplasms - complications
/ Testicular Neoplasms - pathology
/ Thromboembolism
/ Thrombosis
/ Tomography
/ Tumors
/ Urology
/ Venous Thromboembolism - etiology
2017
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
by
Gary, Thomas
, Samonigg, Hellmut
, Gerger, Armin
, Bauernhofer, Thomas
, Fankhauser, Christian D.
, Hermanns, Thomas
, Beyer, Joerg
, Hutterer, Georg C.
, Posch, Florian
, Ploner, Ferdinand
, Pichler, Martin
, Bezan, Angelika
, Szkandera, Joanna
, Winder, Thomas
, Stotz, Michael
, Pummer, Karl
in
Adult
/ Biology and Life Sciences
/ Chemotherapy
/ Classifiers
/ Empirical analysis
/ Epidemiology
/ Health risk assessment
/ Health risks
/ Hospitals
/ Humans
/ Incidence
/ Internal medicine
/ Lymphadenopathy
/ Male
/ Mathematical models
/ Medical imaging
/ Medical research
/ Medicine
/ Medicine and Health Sciences
/ Metastases
/ Metastasis
/ Mortality
/ Neoplasms, Germ Cell and Embryonal - complications
/ Neoplasms, Germ Cell and Embryonal - pathology
/ Oncology
/ Patients
/ Prediction models
/ Retrospective Studies
/ Risk analysis
/ Risk Factors
/ Testes
/ Testicular cancer
/ Testicular Neoplasms - complications
/ Testicular Neoplasms - pathology
/ Thromboembolism
/ Thrombosis
/ Tomography
/ Tumors
/ Urology
/ Venous Thromboembolism - etiology
2017
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
Journal Article
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
2017
Request Book From Autostore
and Choose the Collection Method
Overview
Patients with testicular germ cell tumors (TGCT) have an increased risk for venous thromboembolism (VTE). We identified risk factors for VTE in this patient cohort and developed a clinical risk model.
In this retrospective cohort study at the Medical University of Graz we included 657 consecutive TGCT patients across all clinical stages. A predictive model for VTE was developed and externally validated in 349 TGCT patients treated at the University Hospital Zurich.
Venous thromboembolic events occurred in 34 (5.2%) patients in the Graz cohort. In univariable competing risk analysis, higher clinical stage (cS) and a retroperitoneal lymphadenopathy (RPLN) were the strongest predictors of VTE (p<0.0001). As the presence of a RPLN with more than 5cm in greatest dimension without coexisting visceral metastases is classified as cS IIC, we constructed an empirical VTE risk model with the following four categories (12-month-cumulative incidence): cS IA-B 8/463 patients (1.7%), cS IS-IIB 5/86 patients (5.9%), cS IIC 3/21 patients (14.3%) and cS IIIA-C 15/70 patients (21.4%). This risk model was externally validated in the Zurich cohort (12-month-cumulative incidence): cS IA-B (0.5%), cS IS-IIB (6.0%), cS IIC (11.1%) and cS IIIA-C (19.1%). Our model had a significantly higher discriminatory performance than a previously published classifier (RPLN-VTE-risk-classifier) which is based on the size of RPLN alone (AUC-ROC: 0.75 vs. 0.63, p = 0.007).
According to our risk stratification, TGCT patients with cS IIC and cS III disease have a very high risk of VTE and may benefit from primary thromboprophylaxis for the duration of chemotherapy.
Publisher
Public Library of Science,Public Library of Science (PLoS)
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.